U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
106141106141GE-148-002: A Phase 2, Open-label, Single-Center Study to Assess GE-148 (18F) Injection PET Imaging to Detect Localized Prostate CancerTerminatedHas ResultsProstate CancerDrug: GE-148 (18F)https://ClinicalTrials.gov/show/NCT01176513
106142106142A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid TumorsWithdrawnNo Results AvailableColon Cancer|Lung Cancer|Cervical Cancer|Renal Cell Carcinoma|Uterine CancerDrug: (18)Fluciclatidehttps://ClinicalTrials.gov/show/NCT01176500
106143106143Palliative 3-Dimensional Conformal Radiation Therapy in Reducing Radiation Side Effects in Patients With Lung Cancer. ICORG 06-34Active, not recruitingNo Results AvailableLung CancerOther: questionnaire administration|Procedure: quality-of-life assessment|Radiation: 3-dimensional conformal radiation therapy|Radiation: palliative radiation therapy|Radiation: whole-brain radiation therapyhttps://ClinicalTrials.gov/show/NCT01176487
106144106144A Phase I Trial of a Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaActive, not recruitingNo Results AvailableMelanoma (Skin)Biological: NY-ESO-1 157-165 (165V)|Drug: Nivolumab|Biological: gp100:280-288 (288V)|Drug: Montanide ISA 51 vegetable grade (VG)|Drug: Ipilimumab|Procedure: Apheresis Procedurehttps://ClinicalTrials.gov/show/NCT01176474
106145106145Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558RecruitingNo Results AvailableMelanoma (Skin)Biological: MART-1|Biological: NY-ESO-1|Biological: gp100:209-217(210M)|Biological: gp100:280-288(288V)|Drug: Montanide ISA 51 VG|Biological: BMS-936558https://ClinicalTrials.gov/show/NCT01176461
106146106146Laser Resurfacing Versus Dermabrasion for Scar RevisionCompletedHas ResultsCicatrix|Dermabrasion|Coagulation, LaserDevice: Fractionated laser|Device: Dermabrasionhttps://ClinicalTrials.gov/show/NCT01176448
106147106147Trial of L-DOPA as a Treatment to Improve Vision in AlbinismCompletedNo Results AvailableAlbinismDrug: Levodopa|Drug: Levodopa|Drug: Levodopahttps://ClinicalTrials.gov/show/NCT01176435
106148106148Telomere and TelomeraseTerminatedNo Results AvailableAcute Myeloid LeukemiaGenetic: Blood samplehttps://ClinicalTrials.gov/show/NCT01176422
106149106149Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?RecruitingNo Results AvailableHIV Infections|Herpes SimplexDrug: Valacyclovir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01176409
106150106150CAMBRA - PBRN Caries Management By Risk Assessment In A Practice-Based Research NetworkRecruitingNo Results AvailableDental CariesOther: Caries prevention active intervention|Other: control treatmenthttps://ClinicalTrials.gov/show/NCT01176396
106151106151Impact of a Gene Test for Susceptibility to Lung Cancer in SmokersCompletedNo Results AvailableSmoking CessationGenetic: Respiragene test and risk scorehttps://ClinicalTrials.gov/show/NCT01176383
106152106152The Purpose of the Study is to Evaluate Whether the Use of C-Pulseâ„¢ as Treatment for Patients in Moderate to Severe Heart Failure (HF) is Associated With Reasonable Assurance of Safety and PerformanceActive, not recruitingNo Results AvailableHeart FailureDevice: C-Pulseâ„¢ (Implantable Counterpulsation Therapy)|Device: C-Pulseâ„¢ (Implantable Counterpulsation Therapy)https://ClinicalTrials.gov/show/NCT01176370
106153106153Adiponectin and Inflammatory Mediators in Mediastinal Adipose TissuesRecruitingNo Results AvailableCoronary Artery Disease|Atherosclerosishttps://ClinicalTrials.gov/show/NCT01176357
106154106154VItamin D Effect on Osteoarthritis StudyCompletedNo Results AvailableOsteoarthritis, KneeDrug: Vitamin D|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01176344
106155106155Outcomes of 20 and 23-gauge Combined Transconjunctival Pars Plana VitrectomyCompletedNo Results AvailableVitrectomyProcedure: 20 and 23 gauge pars plana vitrectomyhttps://ClinicalTrials.gov/show/NCT01176331
106156106156Erdosteine (Erdotin) Versus Standard Care Plus Placebo on Erdosteine for Treatment of Cough in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)WithdrawnNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: Erdosteine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01176318
106157106157Venous Thromboembolism in Pregnant and Puerperal Women in Denmark 1995-2005CompletedNo Results AvailableVenous Thromboembolismhttps://ClinicalTrials.gov/show/NCT01176305
106158106158Comparison of High Flex and Standard Rotating Platform Total Knee Arthroplasty (TKA)CompletedHas ResultsKnee OsteoarthritisDevice: Rotating Platform High-Flex Cruciate Substituting TKA|Device: Rotating Platform Cruciate Substituting TKAhttps://ClinicalTrials.gov/show/NCT01176292
106159106159Arterial Catheter to Monitor GlycemiaRecruitingNo Results AvailableCritical Illness|HyperglycemiaProcedure: Manual and automated washing of the peripherical lines|Procedure: Automated washing of the peripherical lineshttps://ClinicalTrials.gov/show/NCT01176279
106160106160Open-Label Study of Asfotase Alfa in Infants and Children ≤ 5 Years of Age With Hypophosphatasia (HPP)RecruitingNo Results AvailableHypophosphatasiaDrug: asfotase alfahttps://ClinicalTrials.gov/show/NCT01176266
106161106161Detection of Human Beta Cell Death in Type 1 Diabetes Mellitus (T1DM) by Methylation Specific Polymerase Chain Reaction (PCR)CompletedNo Results AvailableType 1 Diabetes MellitusProcedure: Blood drawhttps://ClinicalTrials.gov/show/NCT01176253
106162106162A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's DiseaseCompletedHas ResultsOrthostatic Hypotension|Parkinson's DiseaseDrug: Droxidopa|Other: Placebohttps://ClinicalTrials.gov/show/NCT01176240
106163106163Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNo Results AvailableIrritable Bowel Syndrome|Digestive System Diseases|Colonic Diseases, Functional|Colitis, Mucous|Colon, IrritableDietary Supplement: Kyodophilus multi-strain probiotic capsules|Dietary Supplement: Kyodophilus Matching Placebo Capsuleshttps://ClinicalTrials.gov/show/NCT01176227
106164106164WEANING-Study: "Weaning by Early Versus lAte Tracheostomy iN supratentorIal iNtracerebral BleedingsTerminatedNo Results AvailableIntracerebral HemorrhageProcedure: Early tracheostomy|Procedure: Late tracheostomyhttps://ClinicalTrials.gov/show/NCT01176214
10616510616514-C ADME (Absorption, Disposition, Metabolism and Excretion) Study in ManCompletedNo Results AvailableHealthy SubjectsDrug: SLV337 suspension|Drug: SLV337 capsulehttps://ClinicalTrials.gov/show/NCT01176201
106166106166A Nursing Intervention to Enhance Child Comfort and Psychological Well-Being During and Following PICU HospitalizationCompletedNo Results AvailablePsychological StressOther: Comfort Care|Other: Usual carehttps://ClinicalTrials.gov/show/NCT01176188
106167106167Progesterone Microspheres Pharmacokinetic - Pharmacodynamic (PK-PD) StudyCompletedNo Results AvailableInfertilityDrug: Progesterone|Drug: Progesterone|Drug: Progesterone|Drug: Progesteronehttps://ClinicalTrials.gov/show/NCT01176175
106168106168Aldosterone Resistance in Preterm InfantsCompletedNo Results AvailableNewbornhttps://ClinicalTrials.gov/show/NCT01176162
106169106169Role Of Self-monitoring of Blood Glucose and Intensive Education in Patients With Type 2 Diabetes Not Receiving InsulinCompletedNo Results AvailableType 2 DiabetesBehavioral: SMBG plus intensive educationhttps://ClinicalTrials.gov/show/NCT01176149
106170106170Organizational Skills Interventions for Children With Attention Deficit Hyperactivity Disorder (ADHD)CompletedNo Results AvailableAttention Deficit Hyperactivity DisorderBehavioral: Homework, Organization, and Planning Skills (HOPS) Interventionhttps://ClinicalTrials.gov/show/NCT01176136

* Görseller ve İçerik tekif hakkına sahip olabilir